Sign in
4/A

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001209191-22-036714

Chief Financial Officer gave up 1,102 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
White Lauren Chief Financial Officer 2022-05-26 Shares withheld for taxes −1,102 $7.01 $7,725 2,648 D
Loading xslF345X03/doc4a.xml…